Nifty Pharma Today: Index Gains 0.13% in Early Trade

Quick sector takeaways

• Nifty Pharma rose 0.13% to 26,711.15 in early trade on 8 September 2026, up 35.65 points from the previous close of 26,675.50.
• The index moved between 26,581.15 and 26,739.75 after opening at 26,685.15, placing the latest reading nearer the session high than the low.
• Breadth was mixed: 8 stocks advanced, 11 declined and 1 was unchanged. Granules India, Aurobindo Pharma and Laurus Labs led the gainers, while JB Chemicals & Pharmaceuticals, Alkem Laboratories and Gland Pharma declined.
• Investors can watch whether the index holds above its previous close and whether gains broaden beyond the leading stocks as the session progresses.

Nifty Pharma today: Early-session update

Nifty Pharma today is modestly positive in the opening phase of trade. At 10:00:00 AM IST, the index was at 26,711.15, a gain of 35.65 points, or 0.13%, from 26,675.50 in the prior session. The move places pharma among the positive sectoral pockets in a session where several other tracked NSE sector indices were lower.

The gain, however, comes alongside mixed stock-level participation. The index has remained above its opening level of 26,685.15 at the latest reading, but the difference between advancing and declining stocks indicates that the sector’s upward move is selective rather than broad-based. That makes the performance of larger pharma names and the leading gainers relevant through the rest of the day.

Price snapshot

Nifty Pharma opened at 26,685.15 and subsequently touched an intraday high of 26,739.75 and a low of 26,581.15. The 158.60-point intraday range shows that the index moved on both sides of the previous close before returning to positive territory. Its latest level of 26,711.15 was 28.60 points above the previous close and 28.60 points below the day’s high.

In practical terms, the index recovered from the day’s low and was trading in the upper part of its morning range at the recorded time. The next useful observation is whether it can retain a positive gap over 26,675.50 while the individual stock picture develops.

Sector ranking

Nifty Pharma was the second top gaining sector index in the current early-session comparison. Nifty Metal led with a 0.47% gain, followed by Nifty Pharma at 0.13%. The remaining tracked indices were in negative territory, which places pharma’s positive move in context.

This ranking underlines the relative resilience of pharma in the opening session. Nifty Metal’s 0.47% rise was stronger, while Nifty FMCG’s 0.09% dip was the smallest decline among the indices that were lower. Financial Services was the weakest of the group, down 0.67%.

Constituent breadth

Of the 20 Nifty Pharma stocks, 8 were advancing, 11 were declining and 1 was unchanged. The advance-decline balance therefore remained tilted towards declines despite the index being higher. Such a split shows that gains in select stocks were sufficient to keep the index in the green, while weakness was present across a larger number of names.

Granules India gained 2.06%, Aurobindo Pharma added 1.43%, Laurus Labs rose 1.21%, Biocon advanced 1.20% and Ipca Laboratories was up 1.01%. At the same time, JB Chemicals & Pharmaceuticals fell 3.87%, Alkem Laboratories declined 1.38% and Gland Pharma slipped 1.17%.

Heavyweights versus broader participation

The heavyweight basket presented a divided picture. Divi’s Laboratories rose 0.91% to ₹9,400, while Dr. Reddy’s Laboratories added 0.15% to ₹1,145.90. In contrast, Sun Pharmaceutical Industries declined 0.40% to ₹1,887.40, Cipla fell 0.51% to ₹1,387.90 and Torrent Pharmaceuticals was lower by 0.19% at ₹4,904.50.

This split among prominent names is consistent with the mixed breadth reading. Divi’s Laboratories traded close to its intraday high of ₹9,421, whereas Sun Pharmaceutical Industries remained below its opening price of ₹1,892. These are price observations, not explanations for the sector’s movement.

Key Nifty Pharma stocks

Biggest positive movers

Granules India led the gainers with a 2.06% rise to ₹885.20 after trading between ₹865 and ₹885.80. Aurobindo Pharma followed, up 1.43% at ₹1,683.80, with an intraday high of ₹1,688.50. Laurus Labs gained 1.21% to ₹1,899.40, Biocon rose 1.20% to ₹396.10 and Ipca Laboratories added 1.01% to ₹1,978.90.

These advances supplied the positive side of the sector’s early-session performance. Granules India was just ₹0.60 below its intraday high at the latest price, while Laurus Labs was ₹3.50 below its own high.

Biggest negative movers

JB Chemicals & Pharmaceuticals was the sharpest loser, down 3.87% to ₹2,408.90. Alkem Laboratories fell 1.38% to ₹5,170 and Gland Pharma declined 1.17% to ₹2,939.50. Zydus Lifesciences was down 0.89% at ₹1,146.60, while Natco Pharma slipped 0.62% to ₹833.10.

JB Chemicals & Pharmaceuticals traded in a wide early range of ₹2,380 to ₹2,525.50. Zydus Lifesciences was at its day low at the recorded time, while Gland Pharma was below its opening level of ₹2,979.90.

Stocks to watch next session

• Granules India, after its 2.06% early gain and trade near the day high.
• Aurobindo Pharma, which rose 1.43% and reached ₹1,688.50 intraday.
• Divi’s Laboratories, which was up 0.91% at ₹9,400.
• JB Chemicals & Pharmaceuticals, following its 3.87% decline and broad intraday range.
• Alkem Laboratories, after a 1.38% fall to ₹5,170.
• Sun Pharmaceutical Industries, a heavyweight that was down 0.40% in early trade.

The constructive case

The constructive evidence is visible in the index remaining above both its previous close and opening level at 10:00:00 AM IST. Nifty Pharma was also the second-best performer among the eight tracked sector indices, with only Nifty Metal recording a larger gain. Positive moves in Granules India, Aurobindo Pharma, Laurus Labs, Biocon, Ipca Laboratories and Divi’s Laboratories provided identifiable pockets of strength.

The rebound from 26,581.15 to 26,711.15 also placed the index in the upper portion of its day’s range. Maintaining this position would keep attention on the positive early-session structure.

The cautious case

The main caution is the breadth split: 11 stocks declined against 8 advances, with one unchanged. The index gain was therefore not matched by a majority of its stocks. Weakness in Sun Pharmaceutical Industries, Cipla and Torrent Pharmaceuticals also showed that heavyweight participation was uneven.

In addition, the index was still below its intraday high of 26,739.75. A move back towards the day’s low would alter the early positive picture, while stock-level divergence remains relevant for readers tracking the sector.

Univest Insights

The early reading for nifty pharma today is positive but measured. A 0.13% gain is enough to place the index second among the tracked sector indices, yet it does not by itself indicate broad participation because the advance-decline count favoured losers.

The sector’s gainers were led by Granules India and Aurobindo Pharma, while Divi’s Laboratories added support from the heavyweight group. Their price action helped offset sharper weakness in JB Chemicals & Pharmaceuticals and declines in Alkem Laboratories and Gland Pharma.

For a broader market snapshot, readers can follow the Univest Market View. Within pharma, the balance between advancing and declining stocks will remain as important as the headline index level during the session.

In the next session, watch whether Nifty Pharma holds above 26,675.50 and whether its breadth improves from 8 advancers versus 11 decliners.

Published on 8 September 2026 at 10:02 AM IST

Frequently asked questions

What is Nifty Pharma today?

Nifty Pharma was at 26,711.15 at 10:00:00 AM IST on 8 September 2026, up 35.65 points or 0.13% from the previous close.

What was Nifty Pharma’s previous close?

The previous close was 26,675.50.

What were Nifty Pharma’s intraday high and low?

The index recorded an intraday high of 26,739.75 and an intraday low of 26,581.15.

Why is Nifty Pharma the second top gaining sector index?

Nifty Pharma gained 0.13%, trailing only Nifty Metal, which rose 0.47%, in the tracked sector-index comparison.

Which Nifty Pharma stocks gained the most?

Granules India gained 2.06%, Aurobindo Pharma rose 1.43% and Laurus Labs advanced 1.21% in early trade.

What was the breadth in Nifty Pharma?

There were 8 advancing stocks, 11 declining stocks and 1 unchanged stock.